EMV Capital PLC
LSE:EMVC
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
EMV Capital PLC
Gross Profit
EMV Capital PLC
Gross Profit Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Gross Profit | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
EMV Capital PLC
LSE:EMVC
|
Gross Profit
£2.1m
|
CAGR 3-Years
29%
|
CAGR 5-Years
28%
|
CAGR 10-Years
45%
|
|
|
Smith & Nephew PLC
LSE:SN
|
Gross Profit
$4.2B
|
CAGR 3-Years
4%
|
CAGR 5-Years
6%
|
CAGR 10-Years
N/A
|
|
|
LivaNova PLC
NASDAQ:LIVN
|
Gross Profit
$939.9m
|
CAGR 3-Years
10%
|
CAGR 5-Years
10%
|
CAGR 10-Years
13%
|
|
|
EKF Diagnostics Holdings PLC
LSE:EKF
|
Gross Profit
£26.5m
|
CAGR 3-Years
-5%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
6%
|
|
|
Creo Medical Group PLC
LSE:CREO
|
Gross Profit
£1.9m
|
CAGR 3-Years
-45%
|
CAGR 5-Years
228%
|
CAGR 10-Years
N/A
|
|
|
Inspiration Healthcare Group PLC
LSE:IHC
|
Gross Profit
£20.1m
|
CAGR 3-Years
2%
|
CAGR 5-Years
11%
|
CAGR 10-Years
21%
|
|
EMV Capital PLC
Glance View
NetScientific Plc is a deep tech and life sciences venture capital investment company. The firm identifies, invests in, and builds high-growth companies in the United Kingdom and internationally. The company employs a capital-light investment approach, making use of its balance sheet and syndicating investments through its wholly owned VC subsidiary, EMV Capital Partners Limited. The company secures a mixture of direct equity stakes and carried interest stakes in its portfolio of companies, creating a structure that can support a large portfolio. The company develops customized, proactive investment strategies for its subsidiaries and portfolio companies. The firm has a portfolio of approximately 70 companies with a focus on life sciences, industrials, robotics & artificial intelligence (AI), and sustainability. Its subsidiaries include Glycotest, Inc., and ProAxsis Limited, among others.
See Also
What is EMV Capital PLC's Gross Profit?
Gross Profit
2.1m
GBP
Based on the financial report for Jun 30, 2025, EMV Capital PLC's Gross Profit amounts to 2.1m GBP.
What is EMV Capital PLC's Gross Profit growth rate?
Gross Profit CAGR 10Y
45%
Over the last year, the Gross Profit growth was 47%. The average annual Gross Profit growth rates for EMV Capital PLC have been 29% over the past three years , 28% over the past five years , and 45% over the past ten years .
